BP000808-PRO-266: Recombinant Human Proteasome Activator Subunit 1
Source: E. coli-derived.
A single, non-glycosylated polypeptide chain containing 269 amino acids (1-249a.a.) and having a molecular mass of 30.8 kDa.
Purity > 90%, by SDS-PAGE.BP001338-PRO-431: Recombinant Human Leukocyte-Associated Immunoglobulin-Like Receptor 1 (LAIR1) Protein
Source: Escherichia Coli-derived.
Purity: > 95% by SEC-HPLC and SDS-PAGE.BP001353-PRO-923: Recombinant Human Oxidized Low-Density Lipoprotein Receptor 1 (OLR1) Protein
Source: E. coli-derived.
Purity: >90.0% as determined by SDS-PAGE.BP000087-CYT-359: Recombinant Rat Interferon-Gamma (IFNγ) Protein
Source: E. coli-derived.
The specific activity as determined by the cytopathic affect inhibition assay with murine L929 cells chalenged with EMC virus was < 0.1 ng/ml, corresponding to a specific activity of 10 MU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000087-CYT-402: Recombinant Porcine Interferon-γ (IFNγ) Protein
Source: E. coli-derived.
The ED50 as determined by the amount of interferon that inhibited 50% of the cytopathic effect of vesicular stomatitis virus in MDBK cells was found to be 0.2-0.6 ng/ml corresponding to a Specific Activity of 1.6-5 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000087-CYT-478: Recombinant Human Interferon-γ (IFNγ) Protein, His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000087-GD24: Recombinant Human Interferon-gamma (IFNγ) Protein
Source: E. coli-derived.
The specific activity as determined in a viral resistance assay using VSV-WISH cells was found to be greater than 1.5 x 107 IU/ mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).